Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Home/Defence Sector/BHEL Share price Analysis April 2026
Defence Sector

BHEL Share price Analysis April 2026

By Zumedha Research Team on April 22, 2026 10 Min Read
BHEL – Zumedha Equity Research
Zumedha Equity Research
Research . Analysis . Insights
NSE: BHEL   CMP
₹333.64
as on 22 Apr 2026
SPECULATIVE BUY
Bharat Heavy Electricals Limited
Navratna PSU · Power Plant Equipment Manufacturer · Ministry of Heavy Industries, GoI
NSEBHEL
BSE500103
ISININE257A01026
Face Value₹2
52W High / Low₹336.80 / ₹205.12
Mkt Cap₹1,15,828 Cr
Promoter Holding58.20%
IndexNifty 100, BSE 200
01 — OVERVIEW
Business Overview
⚠ TURNAROUND STORY · Speculative Rating · High Order Book, Low Current Margins · Execution Risk Elevated
FY26 Revenue (Prov.)
₹32,350 Cr
▲ 18% YoY
FY26 Order Book
₹2,40,000 Cr
▲ Record: 7.4x Revenue
FY26 Order Inflows
₹75,000 Cr
▲ Power + Industrial
PAT Margin (TTM)
~1.9%
⚠ Key Concern

Bharat Heavy Electricals Limited (BHEL), incorporated in 1964 and headquartered in New Delhi, is India’s largest integrated power plant equipment manufacturer and engineering conglomerate under the Ministry of Heavy Industries. It is a Navratna PSU with operations spanning 17 manufacturing divisions, 2 repair units, 4 regional offices, 8 service centres, and project sites across India and internationally in over 90 countries.

BHEL operates across two primary segments. The Power Segment (contributing ~71% of revenue) designs, manufactures, and provides EPC services for thermal, hydro, nuclear, and gas power plants, boilers, steam turbines, turbo-generators, heat exchangers, and balance-of-plant equipment. The company supplies equipment to approximately 53% of India’s total conventional installed power capacity. The Industry Segment (~29% revenue) serves rail transportation (EMUs, locos), defence & aerospace (radar, naval guns, submarine systems), oil & gas, transmission, industrial equipment, and the emerging coal-to-chemicals vertical.

BHEL’s signature competitive advantage is its vertically integrated manufacturing capability — it is one of the very few global companies capable of handling full-scope EPC contracts for large-scale power plants, including design, manufacturing, construction, and commissioning from a single source. It is also uniquely positioned in India’s nuclear energy ambitions: BHEL can handle reactor island EPC contracts and has positioned itself as the primary beneficiary of India’s 100 GW nuclear energy target by 2047.

After years of stagnation and near-losses (FY20–FY23), BHEL is now in a structural recovery phase. FY26 provisional revenues of ₹32,350 crore (18% growth) and a record order book of ₹2.4 lakh crore signal strong future revenue visibility. However, the transformation from an order-collector to a high-quality earnings generator remains the central challenge — PAT margins are still below 2%, a stark contrast to its hardware peers. The investment thesis is essentially a bet on BHEL’s ability to execute at scale and convert its massive order book into profits.

Key strategic developments include: formation of Bharat Coal Gasification & Chemicals Ltd (JV with Coal India) for coal-to-chemicals initiative; commissioning of ~8.9 GW of power capacity in FY26; agreement with Korea’s E2S for excitation systems technology; and nuclear energy partnerships supporting 220 MW PHWRs at multiple sites. The company also commissioned India’s first upgraded Super Rapid Gun Mount (SRGM) onboard INS Nilgiri, demonstrating growing defence electronics capability.

02 — FINANCIALS
Historical Financials
Metric (₹ Crore)FY22FY23FY24FY25FY26P
Revenue from Operations19,66821,84023,89328,33932,350
EBITDA1,1801,4201,8602,100~2,800
EBITDA Margin (%)6.0%6.5%7.8%7.4%~8.7%
PAT(-28)101282534~814
PAT Margin (%)Neg.0.5%1.2%1.9%~2.5%
EPS (₹)(-0.08)0.290.811.54~2.35
Order Book (₹ Cr)1,40,0001,60,0001,90,0002,00,0002,40,000
Order Inflows (₹ Cr)20,00030,00045,00066,00075,000
Dividend (₹/sh)NilNil0.250.50~0.75e
Debt-to-Equity0.48x0.42x0.44x0.45x~0.40x

P = Provisional/Unaudited. e = Estimated. Historical figures consolidated from exchange filings.

BHEL’s financial journey over the past four years reads like a classic deep-value turnaround narrative. The company emerged from near-insolvency (FY22 loss) to progressively expanding profits, though margins remain thin and far below historical highs of 10–12% seen in the 2010–2015 period. The most remarkable development is order momentum: inflows have nearly quadrupled from ₹20,000 Cr (FY22) to ₹75,000 Cr (FY26), and the backlog of ₹2.4 lakh crore represents ~7.4x current annual revenue — among the highest revenue-coverage ratios for any Indian capital goods company. This backlog is the core structural pillar of the bull case.

The Q3 FY26 results offered early evidence of execution improvement: PAT of ₹390 crore in a single quarter (up ~190% YoY from ₹134 crore in Q3 FY25), and revenue of ₹8,700 crore in Q3 FY26 vs. ₹5,670 crore in Q3 FY25. If this trajectory sustains, FY27 could see PAT crossing ₹2,000 crore, dramatically reducing the valuation concern of 144x P/E on trailing earnings.

03 — VALUATION
DCF Valuation
DCF
DISCOUNTED CASH FLOW · 10-YEAR PROJECTION · WACC 12% · TERMINAL GROWTH 4%
₹1,200 Cr
~3.5% FCF margin; ramp year
40–50%
From a low base; execution-dependent
4%
Conservative vs. BEL’s 5% (lower ROE)
DCF INTRINSIC VALUE
₹260
Base case; current CMP of ₹333 = 28% premium to intrinsic value
BULL CASE DCF (FY28 EPS ₹6+)
₹380
If margin recovery accelerates to 5%+ PAT by FY28
⚠ DCF CAVEAT: BHEL’s DCF is highly sensitive to margin recovery assumptions. At current ~2.5% PAT margin, the stock trades at a significant premium to intrinsic value. Valuation is essentially forward-looking — investors are buying FY28–FY30 earnings, not FY26 earnings. This makes it speculative. Terminal growth rate of 4% (vs. 5% for BEL) reflects BHEL’s lower structural return on equity (~2–4% currently vs. BEL’s 38%).

BHEL’s current trailing P/E of ~144x is technically extreme and is best understood as a mean-reversion trade. If PAT normalises to ₹2,500 crore by FY27 (plausible given Q3 FY26 run-rate), the forward P/E on FY27E earnings drops to ~46x — more palatable for a capital goods company with a ₹2.4 lakh crore order book. The appropriate valuation frame is EV/Order Book (0.5–0.6x) or Price/Book (4–5x), both of which imply fair value closer to ₹280–₹330 on a conservative basis and ₹380–₹420 in a bull scenario.

04 — BUY RANGE
Buy Range
AGGRESSIVE BUY
Below ₹240
Deep value with margin of safety; EV/Order Book < 0.45x
SPECULATIVE BUY
₹240 – ₹310
Current thesis zone; stagger with risk awareness
HOLD / AVOID FRESH
₹310 – ₹380
CMP ₹333 is here ▸ premium to DCF; only hold existing

At CMP of ₹333, BHEL is trading at ~28% premium to our base-case DCF fair value of ₹260, and at ~144x trailing P/E. The market is pricing in a significant improvement in execution and profitability — which may well materialise given the record ₹2.4 lakh crore order book, FY26 GW commissioning milestones, and nuclear power opportunity. However, this makes it a speculative investment rather than a value play. Fresh investors should ideally wait for a pullback below ₹280–₹300 before initiating. Existing holders with a 3–5 year horizon can hold.

05 — SCENARIO ANALYSIS (BUY)
Buy Scenario Analysis
BEAR CASE
₹160
Probability: 25%
Execution continues to lag massive order book; margins stagnate at 2–3%; private sector competition intensifies; power capex cycle slows; working capital deteriorates further; stock re-rates to 2x book value.
BASE CASE
₹340
Probability: 50%
Steady margin improvement to 4–5% PAT by FY28; annual order inflows of ₹70,000–80,000 Cr; GW commissioning of 10–12 GW per year; nuclear project starts adding revenue from FY28; EPS reaches ₹5–6 by FY28.
BULL CASE
₹520
Probability: 25%
Rapid margin recovery to 7–8% PAT on execution efficiency; nuclear energy orders accelerate post government policy push; coal gasification JV scales; defence & railway segments surprise positively; EPS ₹8–10 by FY28.
06 — SELL RANGE
Sell Range
REDUCE
₹380 – ₹440
Book 30–50% of position; significant premium to fair value
EXIT / BOOK
₹440 – ₹520
Unless margin surprise is dramatic; exit majority position
AVOID FRESH BUY
Above ₹380
Risk-reward unfavourable; wait for pullback below ₹280
07 — SCENARIO ANALYSIS (SELL)
Sell Scenario Analysis
OVERVALUED
₹380–₹440
At these levels, BHEL needs PAT of ₹4,000+ Cr (FY28E) to justify valuation — possible but speculative. Reduce position materially.
EXIT TRIGGER
₹440–₹520
Q3/Q4 FY27 results disappoint; margins fail to improve; order cancellations or major disputes materialise; MB Power type LOI withdrawals multiply.
STRUCTURAL BREAK
Below ₹200
Any government action to dilute stake beyond 25%; restructuring rumours; prolonged working capital crisis; power sector NPA cycle resumes. Full exit warranted.
08 — GROWTH & EARNINGS
Future Growth & Earnings Outlook
Revenue CAGR (FY26–28E)
18–20%
▲ Backlog execution
EPS FY27E
₹4.50
▲ ~90% growth YoY
EPS FY28E
₹6.50
▲ ~44% growth YoY
FWD P/E (FY28E)
51x
⚠ Still elevated

Power Segment Growth Engine: BHEL secured ₹59,000 crore in power orders in FY26 alone, maintaining its dominant position in India’s thermal power capex cycle. With India targeting 80 GW of additional thermal capacity addition by 2032 and 100 GW of nuclear by 2047, BHEL’s order pipeline is structurally secured for a decade. FY26 saw commissioning of ~8.9 GW — an accelerating trend as older orders reach completion stages.

Nuclear Energy Optionality: BHEL is uniquely positioned for India’s nuclear ambitions. As one of very few companies globally that can handle reactor island EPC contracts (~₹10 crore per MW), BHEL could win orders worth ₹50,000–₹1,00,000 crore over the next 10–15 years from the nuclear program alone. This is not in current consensus estimates and represents significant option value. Policy announcements on the nuclear programme are a key positive catalyst to watch.

Industry Segment Diversification: BHEL secured ₹16,000 crore in industrial orders in FY26 across transportation (EMU rakes), defence (naval guns, radar), transmission, and coal gasification. The Bharat Coal Gasification JV (with Coal India) to produce ammonium nitrate from domestic coal is a decade-long growth platform targeting ₹10,000+ crore in project contracts. Railway electrification and metro projects add further annuity-type revenue streams.

Margin Trajectory — The Key Variable: BHEL’s PAT margin expansion from 1.9% (FY25) to potentially 5–8% (FY28) is the single biggest earnings driver. The structural enablers include: better project mix (higher-margin complex systems), improved working capital management, and operating leverage on a largely fixed cost base. The risk is that raw material cost inflation, legacy project disputes (like the Raichur Power Corp ₹143 Cr dispute), or execution delays prevent this margin recovery.

09 — RISKS & CATALYSTS
Risks & Catalysts
CATALYSTS (BULL)
Nuclear energy policy announcement: GoI declares specific plant sanctions; BHEL gets EPC mandate worth ₹20,000+ Cr
PAT margin crosses 4% in Q1 FY27 results, confirming structural recovery thesis
Large international EPC order win (Africa, Southeast Asia, Middle East) worth ₹5,000+ Cr
Coal gasification JV secures first large plant contract — new high-margin vertical validates
Upgrade to Navratna+ or government injecting preferential capital for capacity expansion
Disinvestment ruled out formally; government signals long-term ownership commitment
RISKS (BEAR)
Continued margin stagnation: raw material cost inflation, subcontractor disputes, and complex project cost overruns erode profitability
Large order cancellations: LOI withdrawals (like MB Power/Anuppur) multiply; order book quality deteriorates
Working capital deterioration: receivables from state discoms remain stuck; liquidity crunch in project execution
Private sector competition from L&T, Thermax, ISGEC Heavy Engineering wins larger share of new thermal and industrial capex
Coal-to-power transition risk: accelerated renewable push reduces new thermal orders from FY29 onwards
Wage revision, pension liabilities, and PSU bureaucratic inertia limiting rapid operational improvement
10 — PEERS
Peer Comparison
CompanyMkt Cap (Cr)Revenue (Cr)PAT MarginP/E (TTM)EV/EBITDAOrder BookRoCE (%)Rating
BHEL ★1,15,82832,350~2.5%144x54x₹2,40,000 Cr~4%Spec. Buy
L&T4,80,0002,40,000~8.5%28x18x₹5,50,000 Cr~14%Buy
Thermax35,00010,500~6.8%48x30x₹12,000 Cr~22%Hold
Siemens India1,42,00022,000~8.2%52x32x₹15,000 Cr~18%Hold
ABB India80,00012,000~11%58x35x₹10,000 Cr~25%Hold
BEL3,30,03726,750~22.3%55x–₹74,000 Cr~38%Accumulate

BHEL’s peer comparison reveals the stark reality: it is a revenue giant with sub-par profitability metrics. L&T, Thermax, Siemens, and ABB all generate significantly higher margins, better ROCE, and more predictable earnings — yet BHEL commands a speculative premium based on its order book scale and turnaround potential. The ₹2.4 lakh crore order book (7.4x revenue) is genuinely exceptional and surpasses even L&T’s coverage ratio, which explains the market’s willingness to award a premium multiple. The critical question is not whether BHEL will grow revenues, but whether it can translate growth into meaningful, sustainable profits.

VERDICT
NSE: BHEL · BHARAT HEAVY ELECTRICALS LTD
SPECULATIVE BUY
12-MONTH TARGET
₹340
~2% from CMP ₹333 | Bull: ₹420 | Bear: ₹220
VALUATION
144x FY26E EPS
DCF Base: ₹260 | P/B: 4.75x
BHEL is one of the most debated stocks in the Indian capital goods universe — simultaneously carrying the country’s largest engineering order book and some of its lowest profit margins. Our analysis yields a Speculative Buy rating, acknowledging that while the turnaround is underway (FY26 provisional revenues up 18%; order book at a record ₹2.4 lakh crore; Q3 FY26 PAT surging 190% YoY), the current market price of ₹333 already prices in a significant degree of success. The base-case DCF value of ₹260 sits 21% below current market price, making this a momentum-and-execution story rather than a margin-of-safety investment.

The multi-year bull case is genuinely compelling: BHEL’s strategic positioning in thermal, nuclear, and industrial EPC with a ₹2.4 lakh crore backlog provides near-certainty of revenue growth through FY30. If PAT margins normalise to 5–7% by FY28–29 (vs. 2.5% today), earnings could reach ₹5,000–₹8,000 crore, at which point even a modest 30x P/E would yield a stock price of ₹440–₹700 — a 30–110% upside from current levels. The nuclear energy optionality alone (100 GW by 2047; BHEL as primary EPC contractor) is a decade-long earnings catalyst not captured in any current model.

Our recommendation: existing holders should hold with a stop-loss at ₹240 (closing basis). Fresh investors should wait for a pullback below ₹280–₹290 before initiating, at which point the risk-reward improves materially. Position size should be capped at 5–7% of equity portfolio given the speculative nature of the thesis. 12-month target: ₹340 on the base case; bull case of ₹420 if FY27 earnings delivery exceeds consensus.
CMP
₹333.64
Target (Base)
₹340
Buy Below
₹290
Stop Loss
₹240
DISCLAIMER: This report is published by Zumedha Equity Research for informational and educational purposes only. It does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. All data has been sourced from publicly available exchange filings, company announcements, and screener data. Zumedha Equity Research and its principals may or may not hold positions in the securities discussed. Equity investments are subject to market risk. Past performance is not indicative of future returns. Readers are advised to consult a SEBI-registered investment advisor before making investment decisions. The “Speculative Buy” rating indicates above-average risk; investors should assess their personal risk tolerance before acting on this recommendation.
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

BEL Share Price Analysis April 2026

Next

Tata Capital Share Price Analysis April 2026

Legal Disclaimer Investment Research & Information

Not Investment Advice. All content published on this website — including stock analyses, mutual fund reviews, DCF models, valuation estimates, buying zones, and commentary — is created for our own educational, internal research and informational purposes only. Nothing on this website constitutes financial, investment, legal, or tax advice, nor a solicitation or recommendation to buy, sell, or hold any security or financial instrument.

No Guarantees. It is advised clearly and categorically not o follow these analysis and information blindly for your equity investement purpose as Equity investments and mutual funds are subject to market risks. Past performance is not indicative of future results. All DCF models, fair value estimates, and scenario analyses are based on publicly available data and the author's independent assumptions and may prove materially incorrect. The author/s or owners of this website/portal do not are not liable in whatsoever manner for any positive or negative outcome from your own investment endeavorsYou may lose part or all of your invested capital.

Do Your Own Research. Readers are strongly advised to consult a SEBI-registered investment advisor and conduct their own due diligence before making any investment decision. The author may or may not hold positions in securities discussed on this website.

No Obligations. We, the author/ the publisher/ anybody associated with Zumedha.com does not guarantee the accuracy, adequacy or completeness of any information/data and is not responsible for any errors or omissions or for the results obtained from the use of such information/data. Zumedha.com or anyone involved with zumedha.com will not accept any liability for loss or damage as a result of reliance on the Estimates data. It does not subscribe or endorse any of the services and/or content offered by such third party.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
This website is not registered as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013. All views are personal and for informational purposes only.
© 2026 · All Rights Reserved · For Educational Use Only. RESEARCH · ANALYSIS · INSIGHTS